Physician profile
Michael Christopher Donato
NPI 1295703734
$5,532.58
in general payments reported to CMS, 2019-2025
31 companies · $3,664 in 2025
The $3,664 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $84.91 · 2021: $94.46 · 2022: $161 · 2023: $185 · 2024: $1,099 · 2025: $3,664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,402 · Food and Beverage: $1,535 · Consulting Fee: $10.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,401.50 |
| Food and Beverage | $1,535.10 |
| Consulting Fee | $10.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,550.39 | 2024-2025 | |
| Arthrex, INC. | $1,009.90 | 2025 | |
| Fortis Surgical, LLC | $654.71 | 2024-2025 | |
| Stryker Corporation | $255.47 | 2019-2025 | Prostep |
| Paratek Pharmaceuticals, INC. | $177.33 | 2022-2025 | Nuzyra |
| Convatec INC. | $89.95 | 2025 | |
| Linvatec Corporation | $77.14 | 2021-2023 | Rts Flexible 1st Mpj Implant W/Grommets, Colink 2, Colink Vallux |
| Angiodynamics, INC. | $67.27 | 2019 | |
| Averitas Pharma INC. | $60.01 | 2023-2025 | Qutenza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $53.43 | 2020-2023 | Jublia |
| Bioventus LLC | $47.51 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $46.86 | 2021 | |
| Biocomposites INC | $44.68 | 2025 | Stimulan |
| Wright Medical Technology, INC. | $38.56 | 2020 | |
| Smith+Nephew, INC. | $35.59 | 2019-2025 | Collagenase Santyl |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $34.43 | 2022 | |
| Merck Sharp & Dohme LLC | $29.43 | 2019 | |
| Rikco International, LLC | $26.81 | 2019 | |
| Integra Lifesciences Corporation | $26.01 | 2020-2022 | |
| Organogenesis INC. | $23.93 | 2021 | |
| Spr Therapeutics, INC | $23.45 | 2025 | Sprint Pns System |
| Glenmark Therapeutics INC. | $22.00 | 2019 | |
| Reprise Biomedical, INC. | $21.61 | 2025 | Miro3d |
| Amgen INC. | $19.14 | 2025 | Krystexxa |
| Horizon Therapeutics Plc | $18.15 | 2019 | |
| Sebela Pharmaceuticals INC. | $15.22 | 2023 | Pramosone, Naftin |
| Melinta Therapeutics, LLC | $14.63 | 2019 | |
| Medtronic, INC. | $14.31 | 2024 | Intellis Adaptivestim |
| Misonix INC | $13.09 | 2020 | |
| Dynasplint Systems INC. | $10.93 | 2019 | |
| Next Science LLC | $10.64 | 2024 | Surgx, Xperience, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Donato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.